# Recombinant Human Erythropoiet

## EPO inj 1 IU (H-D OPD Only)

*藥物代碼*：IEPO1

*給藥途徑*：I

*用法用量*：

Chronic renal failure Adult patients 
Correction phase: 50 iu/kg 3 times/week IV. When necessary, dose adjustments should be made in increments of 25 iu/kg 3 times/week at intervals of at least 4 weeks until the target Hb concentration (10-12 g/dL ) is achieved. Maintenance phase: Individualised dose. The recommended total weekly dose is 75-300 iu/kg.
Pediatric patients 
Correction phase: 50 iu/kg 3 times/week IV. When necessary, dose adjustments should be made in increments of 25 iu/kg 3 times/week at intervals of at least 4 weeks until the target Hb concentration (9.5-11 g/dL) is achieved. Maintenance phase: Generally, children < 30 kg require higher maintenance doses than children > 30 kg & adults
Cancer patients 
Initially 150 iu/kg 3 times/week. If after 4 weeks the Hb increase is < 1 g/dL the dose should be increased to 300 iu/kg for an additional 4 weeks.


